A Novel VIRTUAL Reality Intervention for CAREgivers of People With Dementia (VirtualCare) (VirtualCare)

March 9, 2023 updated by: Cristina Festari, PhD, IRCCS Centro San Giovanni di Dio Fatebenefratelli

A Novel Virtual Reality Intervention for Caregivers of People With Dementia.

This clinical trial aims to explore if a virtual reality experience increases the beneficial effect of psychoeducational programs in informal caregivers of people with mild-to-moderate Alzheimer's disease. This study will test changes in psychological distress and neural activity in brain systems that regulate stress and empathic care.

Participants will be randomized into two arms: the control group will participate in an online psychoeducational intervention, while the experimental group will participate in the psychoeducational intervention combined with virtual reality.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Brescia, Italy, 25125
        • Recruiting
        • IRCCS Centro San Giovanni di Dio Fatebenefratelli
        • Contact:
        • Principal Investigator:
          • Cristina Festari, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being an unpaid informal caregiver (CG; i.e., family members or friends) living with or caring for a person with Alzheimer's Disease (AD) for at least 4 hours a day for at least six months before enrolment;
  • Caring for a person with a diagnosis of AD at prodromal or mild stage (i.e., Mini-Mental State Examination score:18-24) and still living at home.

Exclusion Criteria:

  • Receiving daily assistance for more than 10 hours from formal CGs;
  • Being formal CGs (i.e., nurse or another paid figure);
  • Being informal CGs of i) persons with moderate-to-severe AD, or ii) persons with non-AD diseases;
  • Not having or being able to use a device connected to internet (e.g., smartphones or PC).
  • Having received psychotherapeutic o psychological support, or having already participated to psychoeducational programs.
  • Only a family member for person with dementia is accepted.

Exclusion Criteria for experimental group (Psychoeducation + VR):

  • Medical history of epilepsy.

Exclusion Criteria for subsample of caregivers assess with MRI:

  • Metal implants, artificial prostheses, pace-makers, prosthetic heart valves;
  • Claustrophobia;
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Psychoeducational program.
6 sessions of 2 hours over 6 weeks
Experimental: Experimental group
Psychoeducational program combined with virtual reality.
6 sessions of 2 hours over 6 weeks. Virtual reality experience will be carry out in the last 30 minutes of each meeting. Virtual reality consists of 360-degree videos depicting everyday situations and allowing the caregivers to feel the specific symptoms of dementia (e.g., disorientation, agnosia, apraxia and memory loss).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in distress of care after intervention
Time Frame: Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
Zarit Burden interview - ZBI
Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
Change in anxiety
Time Frame: Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
State Trait Anxiety Inventory - STAI-Y
Baseline (pre-intervention); Post-intervention (up to a week post-intervention).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in empathy
Time Frame: Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
Interpersonal Reactivity Index - IRI
Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
Change in sense of competence
Time Frame: Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
Short sense of competence questionnaire - SSCQ
Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
Modulation of neural activity in brain systems regulating empathy
Time Frame: Baseline (pre-intervention); Post-intervention (up to a week post-intervention).
Task fMRI
Baseline (pre-intervention); Post-intervention (up to a week post-intervention).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Persistence of medium-term effects - distress of care
Time Frame: 2 months post-intervention.
Zarit Burden interview - ZBI
2 months post-intervention.
Persistence of medium-term effects - anxiety
Time Frame: 2 months post-intervention.
State Trait Anxiety Inventory - STAI-Y
2 months post-intervention.
Persistence of medium-term effects - empathy
Time Frame: 2 months post-intervention.
Interpersonal Reactivity Index - IRI
2 months post-intervention.
Persistence of medium-term effects - sense of competence
Time Frame: 2 months post-intervention.
Short sense of competence questionnaire - SSCQ
2 months post-intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cristina Festari, PhD, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 27, 2022

Primary Completion (Anticipated)

December 30, 2024

Study Completion (Anticipated)

August 1, 2025

Study Registration Dates

First Submitted

February 28, 2023

First Submitted That Met QC Criteria

March 9, 2023

First Posted (Actual)

March 22, 2023

Study Record Updates

Last Update Posted (Actual)

March 22, 2023

Last Update Submitted That Met QC Criteria

March 9, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caregiver Burden

Clinical Trials on Psychoeducation

3
Subscribe